Impact of tumor grade on pancreatic neuroendocrine tumors

被引:13
作者
Shyr, Bor-Shiuan [1 ]
Shyr, Bor-Uei [1 ]
Chen, Shih-Chin [1 ]
Shyr, Yi-Ming [1 ]
Wang, Shin -E [1 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan
关键词
Grade; Neuroendocrine tumor; Neuroendocrine carcinoma; Prognosis; Survival;
D O I
10.1016/j.asjsur.2022.01.094
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background/objective: Pancreatic neuroendocrine tumors (P-NETs) are highly heterogeneous with wide spectrum of biological behaviors and growth patterns. Here, we aimed to assess the impact of tumor grading on P-NETs prognosis and survival outcomes.Methods: Patients with P-NET were recruited to determine correlations between grades and clinico-pathological factors, survival outcomes and prognostic factors.Result: A total of 152 patients with P-NETs were enrolled. G1 P-NET were associated with significantly lower rates of perineural invasion, lymphovascular invasion, lymph node involvement and distant metastasis. The pancreatic head was the most common location of P-NETs. The 1-year, 5-year and 10 -year overall survival rates of the patients were 94.4%, 89.1% and 78.8%, respectively. Majority of pancreatic neuroendocrine carcinoma (P-NEC) were unresectable (90.9%), and P-NECs patients had poor survival rates (1-year, 20% and no 5-year). Male sex, tumor size >= 2.5 cm, perineural invasion, lymph node invasion, metastasis, and advanced stage were significantly associated with poorer survival outcomes. Tumor grade and sex were independent survival predictors. Moreover, tumor grade was the most powerful prognostic factor.Conclusions: Tumor grade, sex, perineural invasion, tumor size, lymph node involvement, metastasis, and stage are survival predictors for patients with P-NETs. Tumor grade is the most powerful independent prognostic factor.(c) 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:2659 / 2663
页数:5
相关论文
共 18 条
[1]   Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: Analysis of 9,821 patients [J].
Bilimoria, Karl Y. ;
Tomlinson, James S. ;
Merkow, Ryan P. ;
Stewart, Andrew K. ;
Ko, Clifford Y. ;
Talamonti, Mark S. ;
Bentrem, David J. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (11) :1460-1467
[2]   Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors [J].
Chawla, Akhil ;
Williams, Richelle T. ;
Sich, Nicholas ;
Clancy, Thomas ;
Wang, Jiping ;
Ashley, Stanley ;
Pezzi, Christopher ;
Swanson, Richard .
JOURNAL OF SURGICAL ONCOLOGY, 2018, 118 (06) :983-990
[3]   Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors [J].
Chen, Hong-Yu ;
Zhou, Ya-Liang ;
Chen, Yong-Hua ;
Wang, Xing ;
Zhang, Hao ;
Ke, Neng-Wen ;
Liu, Xu-Bao ;
Tan, Chun-Lu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (25) :3638-3649
[4]   Gastroenteropancreatic Neuroendocrine Tumors [J].
Cives, Mauro ;
Strosberg, Jonathan R. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :471-487
[5]   A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification [J].
Fang, Jiayun M. ;
Shi, Jiaqi .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (11) :1317-1326
[7]   A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms [J].
Gao, Yong ;
Gao, Hao ;
Wang, Guangfu ;
Yin, Lingdi ;
Xu, Wenbin ;
Peng, Yunpeng ;
Wu, Junli ;
Jiang, Kuirong ;
Miao, Yi .
SCIENTIFIC REPORTS, 2018, 8
[8]   Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor [J].
Harimoto, Norifumi ;
Hoshino, Kouki ;
Muranushi, Ryo ;
Hagiwara, Kei ;
Yamanaka, Takahiro ;
Ishii, Norihiro ;
Tsukagoshi, Mariko ;
Igarashi, Takamichi ;
Tanaka, Hiroshi ;
Watanabe, Akira ;
Kubo, Norio ;
Araki, Kenichirou ;
Hosouchi, Yasuo ;
Suzuki, Hideki ;
Arakawa, Kazuhisa ;
Hirai, Keitarou ;
Fukazawa, Takaharu ;
Ikota, Hayato ;
Shirabe, Ken .
PANCREAS, 2019, 48 (07) :943-947
[9]   The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia [J].
Inzani, Frediano ;
Petrone, Gianluigi ;
Rindi, Guido .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) :463-+
[10]   Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors [J].
Jeune, F. ;
Taibi, A. ;
Gaujoux, S. .
SCANDINAVIAN JOURNAL OF SURGERY, 2020, 109 (01) :42-52